You are here

EU authorizes 2 new medicines for people at risk of severe COVID

Primary tabs

EU authorizes 2 new medicines for people at risk of severe COVID

Thu, 2021-11-11 12:06 — mike kraft

EU authorizes 2 medicines for people at risk of severe COVID AMSTERDAM (AP) — The European Medicines Agency has recommended the authorization of two new medicines against the coronavirus for people at risk of severe disease. In a statement on Thursday, the EU drug regulator said it had concluded that the monoclonal antibody treatments — a combination of casirivimab and imdevimab, and the drug regdanvimab — have both been proven to significantly reduce the risk of hospitalization and death in patients vulnerable to serious COVID-19. AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

Medical - global

Log in or register to post comments

Workflow history

Revision ID	Field name	Date	Old state	New state name	By	Comment	Operations
			No state	No state

Page loaded in 0.446 seconds.